PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic Subdural Hematoma IDE Trial

NCT07576998 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

475

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Subdural Hematomas

Interventions

DEVICE: PHIL™ (Precipitating Hydrophobic Injectable Liquid)
PROCEDURE: Surgical evacuation

Sponsor

Microvention-Terumo, Inc.